Case report reveals glycemic instability and insulin resistance in type 2 diabetes, suggesting modified insulin regimens can improve outcomes.
We report an 80‐year‐old man with type 2 diabetes who presented with life‐threatening hypoglycemia (36 mg/dL) and coma, requiring high‐dose insulin (74 units/day). Exogenous insulin antibody syndrome (EIAS) was suspected due to his glycemic instability and high insulin requirements. Subsequent testing confirmed elevated insulin antibodies (8.7 U/mL). Switching insulin analogues (to 32 units/day) promptly achieved stable glycemic control. This case highlights that EIAS, an under‐recognized cause of unpredictable glycemia in insulin‐treated diabetes, should be considered in patients with severe hypoglycemia and high insulin requirements. Modifying the insulin regimen is key for diagnosis and treatment.
No takes yet. Share an insight, caveat, or question.
A 2025 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: